• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    H.C. Wainwright initiated coverage on GRI Bio with a new price target

    12/9/24 7:50:37 AM ET
    $GRI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GRI alert in real time by email
    H.C. Wainwright initiated coverage of GRI Bio with a rating of Buy and set a new price target of $10.00
    Get the next $GRI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GRI

    DatePrice TargetRatingAnalyst
    12/9/2024$10.00Buy
    H.C. Wainwright
    More analyst ratings

    $GRI
    SEC Filings

    See more
    • GRI Bio Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - GRI Bio, Inc. (0001824293) (Filer)

      5/23/25 7:16:47 AM ET
      $GRI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by GRI Bio Inc.

      424B5 - GRI Bio, Inc. (0001824293) (Filer)

      5/23/25 7:14:51 AM ET
      $GRI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by GRI Bio Inc.

      10-Q - GRI Bio, Inc. (0001824293) (Filer)

      5/15/25 8:38:34 AM ET
      $GRI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • H.C. Wainwright initiated coverage on GRI Bio with a new price target

      H.C. Wainwright initiated coverage of GRI Bio with a rating of Buy and set a new price target of $10.00

      12/9/24 7:50:37 AM ET
      $GRI
      Biotechnology: Pharmaceutical Preparations
      Health Care